0000899243-19-016823.txt : 20190613 0000899243-19-016823.hdr.sgml : 20190613 20190613163134 ACCESSION NUMBER: 0000899243-19-016823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190611 FILED AS OF DATE: 20190613 DATE AS OF CHANGE: 20190613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cima Michael J. CENTRAL INDEX KEY: 0001615992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 19896443 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-11 0 0001492674 T2 Biosystems, Inc. TTOO 0001615992 Cima Michael J. 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Common Stock 2019-06-11 4 S 0 3240 1.43 D 213178 D The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2019, to cover payment of tax liability incident to the vesting of restricted stock units. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.47. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John Sprague, Attorney-in-fact 2019-06-13